Levetiracetam IV Dosing in Children
For pediatric status epilepticus, administer levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) over 15 minutes, followed by maintenance dosing of 15-30 mg/kg IV every 12 hours depending on seizure type and clinical context.
Loading Dose for Status Epilepticus
The most recent and highest-quality guideline evidence establishes clear weight-based dosing for acute seizure management 1:
- Loading dose: 40 mg/kg IV bolus (maximum 2,500 mg)
- Administration time: 15 minutes
- This dose applies to both convulsive and non-convulsive status epilepticus
This loading dose is given in addition to any maintenance dose the patient may already be receiving 1.
Maintenance Dosing After Status Epilepticus
Maintenance dosing varies by seizure type 1:
For non-convulsive status epilepticus:
- 15 mg/kg IV every 12 hours (maximum 1,500 mg per dose)
For convulsive status epilepticus:
- 30 mg/kg IV every 12 hours, OR
- Increase prophylaxis dose by 10 mg/kg (to 20 mg/kg) IV every 12 hours
- Maximum single dose: 1,500 mg
Standard Dosing for Non-Emergent Use
For children requiring IV levetiracetam when oral administration is temporarily not feasible 2:
Initial dosing:
- Start at 500 mg twice daily for children ≥16 years
- Increase by 500 mg twice daily every 2 weeks
- Maximum recommended dose: 1,500 mg twice daily
Pediatric considerations from research evidence:
- Studies support loading doses of 20-60 mg/kg in children 3, 4
- A prospective safety study demonstrated that 50 mg/kg (maximum 2,500 mg) over 15 minutes was well-tolerated in children 6 months to <15 years 3
- Maintenance doses of 20-30 mg/kg/day divided twice daily are commonly used 5, 6
Critical Dosing Considerations
Renal adjustment is mandatory: Levetiracetam is predominantly renally eliminated, and dose adjustment based on creatinine clearance is necessary 2. The optimal maintenance dose can be calculated as 20.7 mg/mL/min of estimated glomerular filtration rate 5.
Age-specific factors:
- Younger children (<4 years) may require higher weight-based doses due to increased clearance 6
- Infants and young children often need maintenance doses at the higher end of the range (28-30 mg/kg/day) 6
Administration details:
- Administer over 15 minutes 2, 3
- Do not dilute the premixed formulation 2
- Available concentrations: 5 mg/mL, 10 mg/mL, and 15 mg/mL 2
Safety Profile
Levetiracetam demonstrates excellent tolerability in pediatric populations 3, 6, 4:
- No serious adverse reactions in prospective pediatric studies
- Minor reactions include somnolence, fatigue, and restlessness
- Significantly fewer cardiovascular effects compared to phenytoin
- No respiratory depression (unlike benzodiazepines and barbiturates)
Common pitfall: Unlike phenytoin, levetiracetam does not require cardiac monitoring during infusion and has minimal risk of hypotension or arrhythmias 1.
Clinical Context
When to use the 40 mg/kg loading dose: This higher loading dose is specifically for status epilepticus management and should be administered after benzodiazepines as second-line therapy 1.
When to use lower doses: For routine conversion from oral to IV therapy in stable patients, use equivalent daily dosing divided every 12 hours, typically starting at lower weight-based doses and titrating up 2.
Important caveat: While the FDA label primarily addresses adults ≥16 years 2, the pediatric guideline evidence from Nature Reviews Clinical Oncology (2019) provides the most authoritative dosing for status epilepticus in children 1, and this should take precedence for acute seizure management.